PT Bank Neo Commerce Tbk

The company maintains a strong liquidity position, with a liquidity_fpt of 1.4x, indicating sufficient cash flow to cover short-term obligations. Its free cash flow of 585.05 billion IDR supports operational flexibility, while the debt-to-equity ratio of 0.05 suggests a conservative capital structure. The return on equity of 13.37% and return on assets of 2.98% indicate solid profitability relative to its equity base and total assets.

Profitability metrics align with the industry's preferred KPIs, particularly in terms of return on equity. The ROE of 13.37% exceeds the median for banks in the region, reflecting efficient use of equity capital. However, the ROA of 2.98% is in line with the industry median, suggesting that asset utilization is average.

The company's revenue is concentrated in its domestic market, with no disclosed international operations. This geographic concentration may expose the company to local economic fluctuations. The absence of segment-specific revenue data limits the ability to assess diversification within the business.

Outlook for the current fiscal year shows a projected revenue growth of 8.2%, driven by expansion in digital services and customer acquisition. The next fiscal year is expected to see a 5.1% increase, reflecting continued market penetration and operational efficiency. Historical revenue growth has averaged 7.5% annually over the past three years, supporting the forward-looking projections.

Risk factors include medium liquidity risk due to negative net cash after subtracting total debt, and low dilution potential as shares outstanding remain unchanged between basic and diluted measures. No significant dilution sources were identified in recent filings. The company's capital expenditure of -51.998 billion IDR indicates a reduction in investment, which may affect long-term growth capacity.

Recent events include the filing of the 2023 annual report, which disclosed continued investment in digital infrastructure and customer service improvements. No material adverse events were reported in the latest earnings call transcripts.